Lancet Oncology, 22, 29-42 Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045(20)30555-6 The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC The Lancet. Oncology r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname Lancet Oncology, 22, 1, pp. 29-42 The Lancet Oncology, 22(1), 29-42. ELSEVIER The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group lancet oncology, 22(1), 29-42. Lancet Publishing Group